“Silent” Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents-Reference-Cited by-同舟云学术

“Silent” Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents

Published:2018-03 Issue:5 Volume:11 Page:448-459
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

von Birgelen Clemens,Kok Marlies M.,Sattar Naveed,Zocca Paolo,Doelman Cees,Kant Gert D.,Löwik Marije M.,van der Heijden Liefke C.,Sen Hanim,van Houwelingen K. Gert,Stoel Martin G.,Louwerenburg J. (Hans) W.,Hartmann Marc,de Man Frits H.A.F.,Linssen Gerard C.M.,Doggen Carine J.M.,Tandjung Kenneth

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Hyperglycemia and cardiovascular disease in type 2 diabetes;Laakso;Diabetes,1999

2. Metabolic syndrome with and without C-reactive protein as a predictor as coronary heart disease and diabetes in the West of Scotland coronary prevention study;Sattar;Circulation,2003

3. Strategies for multivessel revascularization in patients with diabetes;Farkouh;N Engl J Med,2012

4. Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials;Kedhi;J Am Coll Cardiol,2014

5. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting (DIABETES) trial;Sabate;Circulation,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention;Cardiovascular Diabetology;2024-03-30

2. The Relationship between Admission Blood Glucose Levels and Major Adverse Cardiovascular Events during Hospitalization in Non-Diabetic ST-Segment Elevation Myocardial Infarction (Killip I) Patients Undergoing Primary Percutaneous Coronary Intervention;2023-09-08

3. Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities;International Journal of Molecular Sciences;2023-06-18

4. HbA1c-based rather than fasting plasma glucose-based definitions of prediabetes identifies high-risk patients with angiographic coronary intermediate lesions: a prospective cohort study;Cardiovascular Diabetology;2023-03-25

5. Hyperglycemia newly detected by glycated hemoglobin affects all-cause mortality in coronary artery disease patients: a retrospective cohort study;Diabetes Research and Clinical Practice;2022-09